Company Profile

Greenwings Biomedical Inc
Profile last edited on: 6/12/2020      CAGE: 86JJ8      UEI: ZAQWCTMCWSK1

Business Identifier: Privately held incubator licensing from local universties, housing the research work in its labs, raising capital and achieving liquity event.
Year Founded
2013
First Award
2019
Latest Award
2019
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

12321 OCEAN PARK Boulevard UNIT 14
Los Angeles, CA 90064
   (310) 807-5786
   N/A
   www.greenwingsbiomedical.com
Location: Single
Congr. District: 37
County: Los Angeles

Public Profile

Launched by an LA based serial entrepreneur and angel investor, Greenwings Biomedical Inc is not itself an SBIR firm. Rather, it is an incubator anchored in the research efforts of local universities. Greenwings Biomedical incubates exceptional biomedical innovations into exceptional ventures. We translate promising biomedical inventions and technologies from research projects into successful products, and bring these to the market by either getting the projects acquired in early-exit transactions or launching independent, commercial ventures. Our focus is on biomedical devices, software and digital-health products enabled at their core by highly innovative algorithms and software-based intelligence. Of particular interest are solutions that will significantly improve the cost and quality of healthcare by advancing clinician productivity, clinical decision support, personalized medicine, non-invasive therapy, coordination of care, and patient management and engagement. Some examples are diagnostic, monitoring and therapeutic devices; medication management; telemedicine; healthcare information systems; analytics and data visualization; bioinformatics; and quantified-self and wearable devices. We license intellectual property from universities and corporations, and partner with individual inventors. In full collaboration with the original researchers and inventors, our multidisciplinary team of entrepreneurs, engineers, clinicians and subject-matter experts closes the gap between the earliest stages when ideas are still in the lab and the creation of clinically validated, commercial-ready products. Our first major value-creating milestone in every project is to develop a product that demonstrates clinical and market viability. The second major milestone is to attract capital and an A-team to launch the project as an independent venture. The third major milestone is for the launched venture to bring its products to market. And the fourth major milestone is the liquidity event that provides a return to shareholders. The ultimate milestone is to make large, positive differences in people's lives.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2019 1 NIH $175,210
Project Title: EEG-Based Assessment of the Cognitive Impairment of Alzheimer's Disease

Key People / Management

  Richard Koffler